#VisualAbstract: Pridopidine Does Not Impact the Progression of Amyotrophic Lateral Sclerosis
Click here to read this study in JAMA. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced ...
Tag: amyotrophic lateral sclerosis (ALS)
#VisualAbstract: Fasudil is Tolerated and Effective in Amyotrophic Lateral Sclerosis
Click here to read this study in Lancet Neurology. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be ...
Consuming some polyunsaturated fatty acids may help slow the progression of amyotrophic lateral sclerosis
1. In this prospective cohort study, higher blood levels of the polyunsaturated fatty acid (PUFA), alpha-linolenic acid (ALA), were associated ...
Wellness Check: Nutrition
Positioning food and restaurant options in order of ascending energy content promotes lower-energy meal choices 1. In this randomized controlled ...
Variants in the SPTLC1 gene associated with juvenile amyotrophic lateral sclerosis
1. De novo variants in the SPTLC1 gene among unrelated patients were associated with juvenile amyotrophic lateral sclerosis using exome ...
Ezogabine with potential to slow disease progression for amyotrophic lateral sclerosis in phase 2 trial
1. Dose-dependent ezogabine was shown to decrease motor neuron excitability, a marker of disease progression, in patients with amyotrophic lateral ...
#VisualAbstract: Sodium phenylbutyrate-taurursodiol in amyotrophic lateral sclerosis patients
1. Sodium phenylbutyrate-taurursodiol slowed the functional decline in patients with amyotrophic lateral sclerosis. 2. The mean rate of change for ...
Sodium phenylbutyrate-taurursodial in amyotrophic lateral sclerosis patients
1. Sodium phenylbutyrate-taurursodial slowed the functional decline in patients with amyotrophic lateral sclerosis. 2. The mean rate of change for ...
#VisualAbstract: Intrathecal tofersen for amyotrophic lateral sclerosis
1. A 100mg treatment of tofersen was shown to decrease cerebrospinal fluid (CSF) superoxide dismutase 1 (SOD1) concentration in adults ...
Intrathecal tofersen can reduce superoxide dismutase concentration in cerebrospinal fluid of ALS patients
1. A 100mg treatment of tofersen was shown to decrease cerebrospinal fluid (CSF) superoxide dismutase 1 (SOD1) concentration in adults ...